Immunodeficiency and intrinsic IFN resistance are associated with viral breakthrough to HCV therapy in HIV-coinfected patients.
暂无分享,去创建一个
M. Proschan | R. Lempicki | Jun Yang | R. Dewar | M. Polis | H. Masur | A. Neumann | M. McLaughlin | T. Imamichi | V. Nussenblatt | S. Kottilil | H. Highbarger | C. Koratich | C. Rehm | T. Brann | Helene Highbarger